Ratio Therapeutics, Inc.is on a mission to address a broad range of solid tumors through the development of therapeutic and imaging products based on two unique technologies, one of which has already garnered big pharma attention.
Ratio Therapeutics’ origins go back to the lab of co-founder and chief scientific officer John Babich at the Weill Cornell Medical School, where he worked at the department of radiology....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?